Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Mergers & Acquisitions: Page 2
Quest Diagnostics, Northern Light Health broadening access to laboratory services in Maine
Under a strategic agreement, Quest will acquire select assets of Northern Light Health's outreach laboratory services business in an all-cash transaction.
December 8, 2022
CompuGroup Medical acquires Medicus Laboratory Information Systems
The Medicus laboratory information system (LIS) has been installed in more than 1,000 laboratories nationwide.
December 8, 2022
Quest Diagnostics completes acquisition of Summa Health outreach lab services business
Quest said that as a result of the acquisition, physicians and patients in northeastern Ohio will gain access to its test menu and broad health plan relationships.
November 28, 2022
Fulgent Genetics acquires Fulgent Pharma for $100M
Fulgent said that through the acquisition, it will evolve from a genomic diagnostics business to a fully integrated precision medicine company with a focus on oncology.
November 8, 2022
Thermo Fisher Scientific to acquire specialty diagnostics firm The Binding Site Group for $2.6B
U.K.-based Binding Site Group provides specialty diagnostic assays and instruments for the diagnosis and management of blood cancers and immune system disorders.
October 31, 2022
PCL acquires molecular diagnostics testing firm Infinity Laboratories
The acquisition will provide PCL a location in the southern United States from which to bring its testing services to the area.
October 18, 2022
Most Popular
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
Simple blood test can detect PTSD biomarkers
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Illumina NGS software to enable tertiary analysis for oncology, rare disease
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
Serum protein in study predicted which patients might die without a liver transplant
Liquid biopsy diagnostics firm DiaCarta going public on NYSE through SPAC
The equity valuation of DiaCarta under the proposed combination is $460 million. DiaCarta is a translational genomics and molecular diagnostics firm.
October 14, 2022
Beckman Coulter Diagnostics acquires AI clinical decision-support firm StoCastic
StoCastic has developed TriageGo, a triage decision-support tool that will be the cornerstone of Beckman Coulter's AI-enabled clinical decision support portfolio.
October 11, 2022
Report of potential Bio-Rad, Qiagen combination generates mixed investor response
Citing "people familiar with the matter," the
Wall Street Journal
reported that the firms are in discussions to combine in a deal that would be worth more than $10 billion.
October 10, 2022
Clinisys completes corporate rebranding following acquisitions
Clinisys announced that it has completed the acquisition of multiple information systems firms: Sunquest Information Systems, Horizon Lab Systems, and Apollo LIMS.
October 5, 2022
GBS acquires drug screening system developer Intelligent Fingerprinting
Intelligent Fingerprinting has developed an on-the-spot, 10-minute drug screening system that analyzes fingerprint sweat to screen for recent drug use.
October 5, 2022
Quest Diagnostics to acquire Summa Health’s outreach laboratory services business
The all-cash transaction is expected to be completed in the fourth quarter and broaden access to lab services in Ohio.
October 5, 2022
Previous Page
Page 2 of 8
Next Page
